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Mice with targeted deletion of the gene for interleukin-10 (IL-10) spontaneously develop enterocolitis when
maintained in conventional conditions but develop only colitis when kept in specific-pathogen-free (SPF)
environments. This study tested the hypothesis that enteric bacteria are necessary for the development of
spontaneous colitis and immune system activation in IL-10-deficient mice. IL-10-deficient mice were main-
tained in either SPF conditions or germfree conditions or were populated with bacteria known to cause colitis
in other rodent models. IL-10-deficient mice kept in SPF conditions developed colitis in all segments of the
colon (cecum and proximal and distal colon). These mice exhibited immune system activation as evidenced by
increased expression of CD44 on CD41 T cells; increased mesenteric lymph node cell numbers; and increased
production of immunoglobulin A (IgA), IgG1, and IL-12 p40 from colon fragment cultures. Mice populated
with bacterial strains, including Bacteroides vulgatus, known to induce colitis in other rodent models had
minimal colitis. Germfree IL-10-deficient mice had no evidence of colitis or immune system activation. We
conclude therefore that resident enteric bacteria are necessary for the development of spontaneous colitis and
immune system activation in IL-10-deficient mice.
Ulcerative colitis and Crohn’s disease, collectively known as
inflammatory bowel diseases (IBD) in people, are chronic im-
mune-mediated diseases of the intestinal tract with unknown
etiologies. Various pathogenic mechanisms have been pro-
posed, including an appropriate inflammatory response to a
luminal pathogen or abnormal luminal constituent, autoimmu-
nity, or an abnormal immune response to a normal luminal
constituent such as ubiquitous intestinal bacterial or dietary
antigens (43). The hypothesis that aberrant immune responses
to nonpathogenic luminal bacteria can cause colitis is sup-
ported by clinical observations that decreasing intestinal bac-
terial concentrations by various techniques can lead to clinical
improvement and decreased intestinal inflammation (42). The
role of normal resident bacterial flora in the development of
chronic intestinal inflammation has been further demonstrated
in several rodent models of experimental colitis, both induced
and spontaneous. For example, HLA-B27 transgenic rats
raised under specific-pathogen-free (SPF) conditions sponta-
neously develop colitis, gastritis, and arthritis, whereas trans-
genic rats do not develop these lesions when maintained under
germfree conditions (39, 50). Similarly, T-cell receptor-a
knockout mice fail to develop colitis in the absence of normal
bacteria (16). Colitis spontaneously develops in interleukin-2
(IL-2)-deficient mice under conventional housing conditions
but is greatly attenuated in germfree conditions (12, 41, 45).
Severe combined immunodeficient mice repopulated with
CD41CD45 RBhi T cells spontaneously develop a wasting syn-
drome and colitis, but when these T-cell-repopulated mice are
treated with antibiotics, the wasting syndrome improves or
resolves, presumably in conjunction with improvement in in-
testinal inflammation (35). Finally, Lewis rats treated with
indomethacin and antibiotics develop less severe inflammation
than rats treated with indomethacin alone (5, 55). All of these
observations are consistent with intestinal bacteria having a
role in either the initiation or perpetuation of chronic intesti-
nal inflammation. Reconstitution studies of HLA-B27 trans-
genic rats and carrageenan-fed guinea pigs demonstrated that
Bacteroides vulgatus was particularly important to the induction
of colitis in these models (38, 39). Defined bacterial products
may also have an important role in chronic enterocolitis, as
evidenced by the chronic granulomatous inflammation that
develops in response to subserosal injection of sterile pepti-
doglycan-polysaccharide complexes in susceptible Lewis rats
(32).
IL-10 plays a critical role in the shaping of immune re-
sponses. Produced by a variety of cell types, but principally by
activated macrophages and Th2 T cells, IL-10 generally pro-
motes the development of humoral, Th2 cytokine-driven im-
mune responses (reviewed in reference 34). Importantly, IL-10
inhibits the development of Th1 immune responses (19, 20),
primarily by reducing the capacity of macrophages to produce
IL-12, a potent inducer of Th1 immune responses (6, 7, 14, 47,
48). IL-10 has been proposed to exert a regulatory effect in
intestinal mucosa (36, 44). The importance of IL-10 in shaping
mucosal immune responses has been elegantly demonstrated
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by the spontaneous onset of inflammation in the IL-10-defi-
cient mouse (27). IL-10-deficient mice spontaneously develop
enterocolitis when housed in conventional environments, but
when housed in SPF conditions IL-10-deficient mice develop
inflammation limited to the colon, suggesting that resident
enteric flora play a role in the development of spontaneous
colitis in these mice. We addressed the hypothesis that spon-
taneous colitis in IL-10-deficient mice requires the presence of
normal enteric bacterial flora and that various genetically en-
gineered colitis models have a similar profile of dominant
bacterial strains which preferentially induce inflammation.
MATERIALS AND METHODS
Mice. Mice from a C57BL/6 3 129 Ola background, including wild-type and
heterozygous mice and mice with a targeted deletion of the IL-10 gene, were
generously provided from the breeding colony at DNAX, Palo Alto, Calif. (3,
27). The genotype of the mice was confirmed both before and after sacrifice by
analysis of tail tip digests by PCR (27).
Intestinal bacterial population of mice. Germfree (sterile) mice (heterozygous
and IL-10 deficient) were Caesarian derived by one of the investigators (E.B.)
and were maintained according to standard techniques (30) in Trexler flexible
film isolators at the Gnotobiotic Animal Facility of the Center for Gastrointes-
tinal Biology and Disease located at the Laboratory Animal Resources facility of
the North Carolina State University College of Veterinary Medicine, Raleigh.
SPF mice were maintained in a dedicated room at the North Carolina State
University College of Veterinary Medicine or the University of North Carolina
Laboratory Animal Resources facility. The germfree status was monitored every
2 weeks by aerobic and anaerobic culture and gram stain of stool samples and/or
bedding material.
For some studies reported here, adult mice were transferred from the germ-
free environment to either an SPF environment or to Trexler plastic isolators
containing animals populated with either six bacterial species (Bacteroides vul-
gatus, Streptococcus faecium [Group D], Escherichia coli, Peptostreptococcus pro-
ductus, Eubacterium contortum, and Streptococcus avium) isolated from a guinea
pig with carrageenan-induced colitis (B. vulgatus) and patients with Crohn’s
disease (S. faecum, E. coli, P. productus, E. contortum, and S. avium) and referred
to as colitis-related flora, as previously described (39), or B. vulgatus only. Col-
onization of the transferred mice was achieved by placing soiled bedding in the
mouse cages. Studies were approved by the North Carolina State University and
University of North Carolina at Chapel Hill Institutional Animal Care and Use
Committees.
Helicobacter PCR. Fecal DNA was purified with the QIAamp Tissue Kit
(Qiagen Inc., Chatsworth, Calif.) according to the manufacturer’s instructions
and as previously described (2). Five microliters of the fecal DNA preparation
was added to a PCR with Helicobacter-specific primers graciously provided by
Richard Murray (DNAX). Purified Helicobacter DNA from pure cultures served
as positive controls. PCR products were resolved and visualized on a 1.8%
agarose gel stained with ethidium bromide. Fecal samples from SPF, germfree,
and colitis-related-bacteria-colonized mice were tested in identical fashion.
Histopathology. Sections of the stomach, duodenum, jejunum, ileum, and
several regions of the large intestine (representing the cecum and proximal and
distal colon) were fixed in 10% neutral buffered formalin and stained with
hematoxylin and eosin for histologic scoring. Scoring was conducted in blinded
fashion on a scale of 0 to 4 with 0 representing no inflammation and 4 repre-
senting severe inflammation characterized by widespread infiltration with inflam-
matory cells, distortion of architecture, and the presence of crypt abscesses and
ulcers, as previously described and validated (39). The mean histologic colonic
inflammatory score for each mouse was determined by adding the scores for each
section of the large intestine examined (minimum of three sections per mouse)
and dividing the total by the number of sections examined.
Lymphoid cell preparations and culture. Mesenteric lymph nodes (MLN),
which enlarge with colonic inflammation (8), were removed and single cell
suspensions were prepared by gentle teasing. Cells were washed and resuspended
in complete medium (RPMI 1640; Tissue Culture Facility, University of North
Carolina Lineberger Cancer Center, Chapel Hill) supplemented with 5% heat-
inactivated fetal calf serum (Irvine Scientific, Santa Ana, Calif.), 2 mM L-glu-
tamine, 1 mM sodium pyruvate, 0.05 mM 2-mercaptoethanol, 50 mg of genta-
micin (Sigma, St. Louis, Mo.)/ml, and penicillin (100 U/ml)-streptomycin (100
mg/ml)-amphotericin B (0.25 mg/ml) (Gibco, Life Technologies, Grand Island,
N.Y.).
Lymphoid cells were stimulated in vitro with immobilized anti-CD3. Cells were
cultured at 106 cells/ml, 0.2 ml per culture, in 96-well flat-bottom plates (Corning
Costar, Cambridge, Mass.) that were precoated with 10 mg of anti-CD3/ml
(purified by protein A from supernatant of the hamster hybridoma 145-2C11)
(28). In previous studies, no increased cellular proliferation or cytokine secretion
was observed in cultures of cells stimulated with immobilized normal hamster
immunoglobulin, thus ruling out nonspecific stimulation via Fc receptors rather
than via CD3 ligation (52). Concanavalin A (Con A) (2 mg/ml; Sigma) and
lipopolysaccharide (LPS) (25 mg/ml) (E. coli 055: B5) (Difco Laboratories, De-
troit, Mich.) were used as polyclonal stimulators.
Lymphoid cell proliferation was measured by incorporation of [3H]thymidine
for the final 18 h of a 90-h culture. Cells were cultured in triplicate with medium
alone, immobilized anti-CD3, Con A, or LPS. For cytokine detection, duplicate
supernatants of anti-CD3-stimulated cells were collected on day 3 and day 6 after
culture initiation and stored at 220°C until being assayed.
Colon fragment cultures. Cultures of colon fragments from segments of prox-
imal, middle, and distal colon except the cecum were prepared following pub-
lished methods (10). Briefly, colon segments were flushed with phosphate-buff-
ered saline (PBS) to remove fecal contents, opened lengthwise, cut into 0.5- to
1-cm pieces, and shaken vigorously for 30 min in PBS. Tissue was then appor-
tioned to wells (50 to 100 mg of tissue per well) of a 24-well tissue culture plate
(Costar) in duplicate or triplicate, as the amount of tissue permitted, and cul-
tured in 1 ml of complete medium containing antibiotics and the antimycotic
agent as outlined above. The cultures were incubated at 37° for 18 h. Culture
supernatants were collected and stored at 220°C until being assayed.
Lymphokine assays. IL-12 p40 was measured by enzyme-linked immunosor-
bent assay (ELISA) with the commercially available antibodies C15.6 and bio-
tinylated C17.8 (Pharmingen, San Diego, Calif.) for capture and detection, re-
spectively, of the IL-12 p40 subunit. Bound antibodies were detected by using
horseradish peroxidase (HRP)-labeled streptavidin (Kirkegaard and Perry Lab-
oratories [KPL], Gaithersburg, Md.). Concentrations of IL-12 p40 were estab-
lished by comparison of values against a standard curve generated for each assay
with recombinant IL-12 p70 (Pharmingen). IL-12 p40 was measured in duplicate
culture supernatants in each separate experiment.
Immunoglobulin isotype measurements. Immunoglobulins (immunoglobulin
A [IgA], IgG1, and IgG2a) elaborated into colon culture supernatants were
measured by ELISA as previously described (51). Secreted immunoglobulins
represented both newly synthesized and preformed proteins. Reagents for cap-
ture and detection of IgA, IgG1, and IgG2a were affinity purified unlabeled
anti-IgA, anti-IgG1, and anti-IgG2a, and HRP-labeled polyclonal goat anti-IgA,
anti-IgG1, and anti-IgG2a, respectively (Southern Biotechnology, Birmingham,
Al.). Concentrations of immunoglobulins were determined by comparison with
standard curves for purified mouse IgA, IgG1, and IgG2a (Pharmingen), respec-
tively.
Flow cytometry. Preparations of lymphocytes were incubated overnight at 4°C
in culture medium alone or with either rat monoclonal anti-mouse CD44
(IM7.8.1) (53) or anti-mouse CD45RB (23G2) (4). Supernatants containing
these antibodies were prepared in S. Tonkonogy’s laboratory from hybridoma
cultures. For labeling of CD4 cells, cells were washed twice and incubated with
25 mg of fluorescein isothiocyanate (FITC)-labeled goat anti-rat IgG/ml, ab-
sorbed with mouse serum (KPL) for 30 min at 4°C, and then washed twice and
incubated with Tricolor-labeled anti-CD4 (clone CT-CD4; Caltag, South San
Francisco, Calif.). B cells were detected by first incubating the cells for 30 min at
4°C with 12.5 mg of FITC-labeled goat anti-mouse IgA-IgM-IgG (KPL)ml and
then washing the cells twice before detection. Analyses were conducted using a
FACScan (Becton Dickinson, San Jose, Calif.) flow cytometer.
Statistics. Statistical comparison of group means was accomplished by per-
forming one-way analysis of variance with a commercial software package (Sig-
maStat; Jandel Scientific, San Rafael, Calif.). Significance was set at a P value of
,0.05, and differences among groups were identified by the Student-Newman-
Keuls method. For nonnormally distributed data, comparison of median values
was achieved with a Kruskal-Wallis one-way analysis of variance on ranks and
group differences identified by Dunn’s multiple comparison procedure.
RESULTS
Normal resident luminal bacteria induce colitis in IL-10-
deficient mice. To determine the role of enteric bacterial flora
in the pathogenesis of colitis in IL-10-deficient mice, mice were
maintained in either an SPF or germfree environment. Con-
sistent with previously reported results (3, 27), outbred IL-10-
deficient mice reared in SPF conditions developed clinical
signs of intestinal inflammation, as evidenced by weight loss
and diarrhea beginning at 7 weeks of age. Some mice also
developed rectal prolapse. Histologically, colitis was character-
ized primarily by mucosal hyperplasia, mononuclear infiltrates
in the lamina propria, and loss of goblet cells and occasionally
by crypt abscesses, crypt ulcers, and transmural inflammation
(Fig. 1a). All regions of the colon were affected, confirming the
observations of one earlier report (3) but not those of another
in which inflammation was limited to the proximal colon (27).
It should be noted that the distribution of colon lesions in a
given mouse could be quite focal, with severely inflamed areas
of mucosa adjacent to comparatively more mildly inflamed
mucosa. As has been previously reported (3, 27), SPF IL-10-
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deficient mice had no evidence of small intestinal inflamma-
tion. Wild-type mice raised under SPF conditions had no clin-
ical or histological evidence of gastroenteritis or colitis.
In contrast to IL-10-deficient mice reared under SPF condi-
tions, germfree IL-10-deficient mice had no clinical or histo-
logical evidence of colitis (Fig. 1b) and were indistinguishable
from wild-type SPF mice (Fig. 1c). Germfree IL-10-deficient
mice were maintained for up to 6 months, and at all ages they
were histologically indistinguishable from germfree wild-type
mice. The mean histologic inflammatory score (Fig. 2) for
IL-10-deficient SPF mice was 2.1, whereas for all other groups
of mice, the mean histology scores were less than 0.5; the
difference in histology scores between germfree and SPF IL-
10-deficient mice was significant (P , 0.05). These results
indicate that resident enteric bacterial flora are necessary for
the spontaneous development of colitis in IL-10-deficient mice.
Colonization of previously germfree adult mice changes the
pattern of large intestinal inflammation. We noted that some
of our IL-10-deficient mice born in an SPF environment were
colonized by Helicobacter hepaticus, detected by PCR analysis
of stool. Helicobacter sp. has been implicated as a cause of
colitis in some immunodeficient mouse models of colitis (54).
To assess whether intestinal inflammation would develop in
the absence of Helicobacter infection and whether the age of
the host affects the mucosal inflammatory response of a pre-
viously germfree animal when transferred to a microbial envi-
ronment, adult germfree IL-10-deficient and heterozygous
mice were transferred to an SPF environment free of Helico-
bacter. When 20- to 24-week-old IL-10-deficient adult mice
were moved from germfree conditions to SPF conditions free
of Helicobacter sp., the pattern of inflammation changed com-
pared to that for mice moved into an SPF environment at
weaning (3 weeks). The former group of mice exhibited more
severe cecal inflammation following at least 5 weeks of bacte-
rial colonization (Fig. 3; Table 1). With bacterial colonization
of IL-10-deficient mice at adulthood, cecal ulceration and sub-
mucosal inflammation were common, whereas such inflamma-
tion was significantly less in IL-10-deficient mice that were
weaned into an SPF environment, even one in which Helico-
bacter was present (Table 1). Adult IL-10-deficient mice moved
from germfree to SPF conditions had inflammation in other
regions of the colon, though colonic inflammation was not as
severe as cecal inflammation (data not shown). These results
FIG. 1. Resident enteric bacteria are required for colon inflammation in
IL-10-deficient mice. Representative photomicrographs from the middle colon
of (a) an IL-10-deficient SPF mouse, (b) an IL-10-deficient germfree mouse, and
(c) a wild-type SPF mouse. Note the marked mucosal hyperplasia, lamina pro-
pria cellular infiltrates, and crypt abscess (arrow) shown in panel a that are
absent in panels b and c. Magnification, 358.
FIG. 2. Mean colon inflammatory scores of germfree or SPF IL-10-deficient
mice, SPF wild-type mice, and germfree heterozygote mice. Sections of colon
representing at least three areas per mouse were scored in a blinded manner on
a scale from 0 (no inflammation) to 4 (severe inflammation), and the scores were
averaged to calculate mean scores. Median values, 25th and 75th percentiles
(boxes), 10th and 90th percentiles (error bars), outlying values (circles), and
means (dashed lines) are represented by box plots. A statistically different (P ,
0.05) mean (from all other means) is indicated by the asterisk. gf, germfree; ko,
IL-10 deficient; het, heterozygous; wt, wild type.
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suggest that the age of IL-10-deficient mice at the time of
bacterial colonization profoundly affects cecal inflammation.
In addition, these results demonstrate that Helicobacter organ-
isms were not essential for the pathogenesis of colitis in these
mice. Some germfree IL-10-deficient mice were housed with
bedding contaminated with Helicobacter-infected stools but
failed to become positive for Helicobacter as determined by
PCR detection of DNA in the stool in the 4 weeks before
sacrifice (data not shown).
Colonization with selected bacteria that cause colitis in
other rodent models of colitis induces mild, delayed inflam-
mation in IL-10-deficient mice. To further explore the role of
defined bacterial species in the development of spontaneous
colitis in the IL-10-deficient mouse, adult (.20 weeks old)
germfree mice were populated with six colitis-related bacterial
species including B. vulgatus or were colonized with B. vulgatus
alone. Colonization with these groups of bacteria has been
previously shown to promote the development of spontaneous
colitis in HLA-B27/b2 microglobulin transgenic rats (39). Col-
onization of the mice with these organisms was confirmed by
examination of gram stains of fecal samples. In contrast to the
severe inflammation observed in the IL-10-deficient mice after
transfer of germfree adults to SPF conditions without Helico-
bacter, the germfree mice colonized with the colitis-related
group of bacteria or B. vulgatus exhibited only mild inflamma-
tion (Table 2). Inflammation was not observed in the colitis-
related flora group until the animals had been in this environ-
ment for 20 weeks. Even so, the inflammation observed in
these mice was less severe than that observed in the germfree
IL-10-deficient mice moved to SPF (without Helicobacter) at 5
weeks post-colonization. As observed in the mature mice
moved from germfree to SPF conditions, mice moved from
germfree to colitis-related flora conditions had more inflam-
mation apparent in the cecum than other regions of the colon.
Interestingly, two of these mice had overt gastric antral and
duodenal inflammation not observed in the SPF colonized
mice even at longer periods of colonization (data not shown).
Adult mice populated with B. vulgatus for 32 weeks likewise
developed only mild colonic inflammation (Table 2). These
results show that hosts with different genetic abnormalities
(IL-10 deficiency versus overexpression of HLA-B27 trans-
gene) respond differently to the same defined bacterial stimuli.
Germfree IL-10-deficient mice have no evidence of immu-
nologic stimulation or activation. To assess the degree of im-
munological stimulation and activation of mice with different
bacterial stimuli, several parameters were evaluated. Total
numbers of lymphocytes obtained from the MLN of germfree
IL-10-deficient mice were comparable to those obtained from
the MLN of germfree heterozygous mice (Table 3). In con-
trast, SPF IL-10-deficient mice had significantly greater num-
bers of MLN cells than did SPF wild-type mice, consistent with
the presence of an inflammatory response in the colon. Of
note, SPF wild-type mice had over twice the number of MLN
FIG. 3. Cecal inflammation is more severe in germfree IL-10-deficient mice
colonized as adults with a Helicobacter-negative SPF flora than in IL-10-deficient
mice colonized at weaning. Representative histologies from (a) a wild-type SPF
mouse, (b) an IL-10-deficient mouse (15 weeks old) maintained in SPF condi-
tions since 3 weeks of age, (c) an IL-10-deficient mouse raised germfree and then
moved to SPF conditions as an adult and sacrificed 5 to 7 weeks later are shown.
Note the marked mucosal hyperplasia, transmural cellular infiltrates with aggres-
sive submucosal inflammation, and crypt abscess (arrow) shown in panel c com-
pared with the mild mucosal hyperplasia and infiltration limited to the lamina
propria shown in panel b. Magnification, 358.
TABLE 1. Cecal histology scores for IL-10-deficient mice moved as
adults from germfree conditions to Helicobacter-negative SPF












IL-10 deficientb 3 20–24 5 3.67 6 0.33
IL-10 deficient 2 20–24 7 3.13 6 0.125
IL-10 deficient,
raised SPF
22 0c 6–38 1.48 6 0.17*
a Values are means 6 standard errors of the mean. *, significantly different
from other values (P , 0.05).
b IL-10-deficient mice raised germfree and then colonized as adults with SPF
bacteria documented to be free of Helicobacter.
c Mice were colonized from birth.
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cells compared with those of germfree heterozygotes, indicat-
ing stimulation of the mucosal immune system by resident
bacteria. Phenotypic analysis of MLN cells by flow cytometry
demonstrated that germfree IL-10-deficient mice had propor-
tions of CD4 and CD8 T cells that were comparable to those of
SPF wild-type mice (Table 3). In contrast, SPF knockout mice
had lower proportions of CD4 cells than either germfree IL-10
knockouts or wild-type SPF and had greater proportions of
CD8 cells than SPF wild-type mice (Table 3). Additionally, the
levels of CD44, a lymphocyte homing receptor whose expres-
sion is higher on activated and memory T cells than on resting
and naive T cells (1, 29), is higher on CD41 MLN from SPF
IL-10-deficient mice than on CD41 MLN of SPF wild-type
mice (Table 3).
Similar to previous descriptions (3, 15), SPF IL-10 knockout
mice with colitis had evidence of mucosal B-cell activation, as
indicated by the elaboration of more IgA, IgG1, and IgG2a in
supernatants of colon fragment cultures (Fig. 4) than those of
wild-type mice without colitis. Similar patterns were observed
in the sera of these groups of mice (data not shown). In con-
trast to the SPF mice, germfree IL-10-deficient mice had no
significant differences in the concentrations of these immuno-
globulins in colon fragment culture supernatants versus those
of germfree and heterozygote SPF wild-type mice.
IL-10 plays an important role in the regulation of immune
responses by inhibiting macrophage production of IL-12 (14,
47). We hypothesized that in the absence of IL-10, there would
be more IL-12 produced by SPF IL-10-deficient mice than by
other groups. Indeed, while the other groups of mice had
essentially undetectable concentrations of IL-12 p40 in the
colonic culture supernatants, IL-10-deficient SPF mice had
elevated amounts of IL-12 p40 in the gut culture supernatants
(Table 4). Though the level of the biologically active p70 het-
erodimer was not measured, these results support the possi-
bility that, in the absence of IL-10, inflammation is driven by
microbial stimulation of IL-12 production by activated macro-
phages. Furthermore, the combined data indicate that the ab-
sence of luminal bacterial stimulation is associated with no
evidence of activation of the mucosal immune response, de-
spite the lack of IL-10-mediated regulation.
DISCUSSION
IL-10 plays a crucial role in the modulation of immune
responses and recently has been implicated as one of the cy-
tokines mediating mucosal T-cell tolerance (17, 24) to bacterial
antigens. Our results show that normal enteric bacteria are
essential for the development of spontaneous colitis in IL-10-
deficient mice since germfree IL-10-deficient mice had no his-
tologically detectable colitis. In contrast, IL-10 knockout mice
maintained in SPF environments had moderate colitis, compa-
rable in character and severity to that of SPF IL-10-deficient
mice from previous reports (3, 15, 27, 40). Unlike some previ-
ous descriptions in which inflammation was limited to the
proximal colon of IL-10-deficient mice (27), inflammation in
this study was found in all regions of the colon. Interestingly,
severely inflamed areas could lie adjacent to nearly normal
areas of mucosa, similar to the focal nature of the “skip le-
sions” of Crohn’s disease. Also, we present novel data regard-
ing the absence of mucosal immune responses, including IL-12
p40 secretion, in the absence of normal luminal bacteria. These
data also illustrate the importance of age at the time of bac-
terial colonization, the ability of Helicobacter-free bacteria to
stimulate colitis in this model, and the different capacities of
defined bacterial species to induce colitis in different geneti-
cally engineered rodents.
Germfree IL-10-deficient mice displayed none of the im-
mune system activation observed in the SPF IL-10-deficient
mice, indicating that subclinical colitis was not present in the
germfree state. In the absence of viable bacteria, markers of
T-cell activation and in vitro immunoglobulin secretion were
not different from those of germfree heterozygote or SPF wild-
type mice. Although IL-10-deficient SPF mice had increased
concentrations of immunoglobulins in their colonic culture
supernatants, B lymphocytes are not essential to the pathogen-
esis of colitis in IL-10-deficient mice (15). Therefore, elevated
levels of circulating antibody and enhanced mucosal immuno-
globulin production should be considered markers of immune
system activation rather than effector molecules causing tissue
damage. Recent observations that IL-10-deficient mice have
TABLE 2. Mean colon scores for adult IL-10-deficient mice










Six defined bacterial species 5 4 0.39 6 0.1
9 3 0.25 6 0.2
13 3 0.48 6 0.09
20 3 1.17 6 0.4
B. vulgatus 32 4 0.58 6 0.14
SPF (without Helicobacter) 5–7 5 2.23 6 0.18*
a Mice were colonized with a mixture of B. vulgatus, S. faecium (Group D), E.
coli, P. productus, S. avium and Eubacterium contortum or B. vulgatus alone or
were put into a Helicobacter-free SPF environment as described in Materials and
Methods.
b Values are means 6 standard errors of the mean. Colon scores are for both
the cecum and other colon regions. p, significantly different from all other scores
(P , 0.05).
TABLE 3. Mean numbers of MLN cells and proportions of CD41 and CD81 T cells obtained from IL-10-deficient mice, wild-type mice, and
heterozygous mice kept in either SPF or germfree conditionsa
Mouse group No. of MLN cells(106 [no. of mice])
% CD41 T cells
(no. of mice)




SPF wild type 22.7 6 2.2 (29) 36.6 6 2.2 (15) 15.4 6 0.8 (15.3) (15) 88.6 6 5.99 (82.5) (12)
SPF IL-10 deficient 33.4 6 4.0* (25) 28.4 6 1.8* (12) 22.8 6 1.9 (24.1)** (12) 130.3 6 10.14 (127.5)** (14)
Germfree heterozygote 9.5 6 2.1 (6) 36.7 6 2.1 (7) 21.4 6 1.7 (21.1) (7) 101 6 4.56 (100) (7)
Germfree IL-10 deficient 8.9 6 1.2 (12) 35.1 6 1.6 (10) 18.4 6 1.6 (17.9) (10) 97.5 6 2.23 (98) (11)
a Except where indicated values are means 6 standard errors of the mean. *, significantly different mean value compared to those for SPF wild-type, germfree
heterozygote, and germfree IL-10-deficient mice (P , 0.05); **, significantly different median value compared to that for SPF wild-type mice (P , 0.05).
b Median values were used for statistical comparisons because of nonparametric data.
c Fluorescence intensity units.
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anticolonic epithelial cell antibodies (15) thus may mean that
these autoantibodies are a secondary result of epithelial dam-
age in the setting of a dysregulated immune response. More-
over, the pattern of in vitro immunoglobulin secretion with
abundant IgG2a in SPF IL-10-deficient mice is consistent with
a Th1-gamma interferon (IFN-g)-driven immune response (40,
49).
In keeping with a Th1 profile of cytokines, we found that
IL-10-deficient mice with colitis had readily detectable amounts
of IL-12 p40 in culture supernatants of inflamed colon frag-
ments, presumably reflecting increases in biologically active
IL-12 p70 heterodimer. It should be emphasized that these
cultures had no in vitro stimuli to promote IL-12 production,
suggesting that cells residing in the colon were activated in vivo
to produce and secrete IL-12 p40. The production of IL-12 p40
mRNA and biologically active p70 IL-12 from macrophages or
dendritic cells is upregulated in vitro in response to many
stimuli. Live bacteria and bacterial products such as LPS and
lipotechoic acid, as well as prokaryotic DNA, have all been
demonstrated to increase production of IL-12 in vitro (9, 11,
22, 25, 26, 33, 48). Our results suggest that in vivo exposure to
resident luminal bacterial components may likewise stimulate
IL-12 production. IL-12 has recently been incriminated as a
mediator of autoimmune disease induced by bacterial products
(46) and loss of tolerance to resident luminal bacteria in ex-
perimental colitis (17). Furthermore, treatment with neutral-
izing antibodies to IL-12 prevents the development of colitis in
IL-10-deficient mice if treatment is initiated at an early age
before development of severe colitis (40), prevents the devel-
opment of hapten-induced colitis in IL-2-deficient mice (18),
and reverses established inflammation in trinitrobenzene sul-
fonic acid-treated mice (37). Because IL-10 promotes the de-
velopment of Th2 responses by inhibiting macrophage produc-
tion of IL-12 (14), it is not surprising that in the absence of
IL-10, unregulated colonic production of IL-12 could occur in
response to microbial stimulation.
An unexpected finding in this study was the increased sever-
ity of cecal inflammation observed in gnotobiotic IL-10-defi-
cient mice that had been colonized with SPF bacteria as adults
compared with those colonized at weaning with the same or-
ganisms. The difference in the intensity of inflammation may
have been related to the age of the animals and the maturity of
their mucosal immune system at the time of colonization. Not
only is cecal inflammation more aggressive with submucosal
inflammation and mucosal ulceration more common following
colonization of older IL-10-deficient mice, but the onset of
inflammation is more rapid (5 weeks) than in germfree IL-10-
deficient mice colonized at weaning (8 to 12 weeks). The sub-
mucosal pattern of colitis is more aggressive than that seen in
3-month-old HLA-B27 transgenic rats colonized with SPF bac-
teria, which developed cecal inflammation confined to the mu-
cosa which was not significantly worse than colitis in B27 trans-
genic rats born in an SPF environment (39).
H. hepaticus has been recently shown to be associated with
cecal inflammation in several immunodeficient mouse strains
and has been advanced as a putative cause of experimental
colitis in genetically engineered mice (54). However, the de-
velopment of aggressive typhlitis, and to a lesser degree colitis,
in a Helicobacter-free environment does not support an essen-
tial role of Helicobacter in the development of colitis in IL-10-
deficient mice. However, a potential contribution of Helicobac-
ter infection in the pathogenesis of colitis in IL-10-deficient
mice is not excluded. Our observations that resident bacteria in
the absence of Helicobacter can cause colitis are particularly
important given the widespread colonization of IL-10-deficient
mice with this opportunistic pathogen (39a).
FIG. 4. Mean immunoglobulin concentrations in supernatants of cultured colon fragments from mice with different bacterial stimulation. Segments of colon were
minced and cultured, and supernatants were collected 18 h later for immunoglobulin quantitation by ELISA. All values are expressed on an equivalent weight basis.
Median values, 25th and 75th percentiles (boxes), 10th and 90th percentiles (error bars), outlying values (circles), and means (dashed lines inside boxes) are represented
by box plots. Statistically different medians (P , 0.05) (from all other medians in the respective panel) are indicated by asterisks (a) IgG2a concentrations; (b) IgG1
concentrations; (c) IgA concentrations. Abbreviations are the same as those in the legend for Fig. 2.
TABLE 4. Concentrations of IL-12 p40 subunit in supernatants of
colon fragment cultures of IL-10-deficient mice wild-type mice, and
heterozygous mice kept in either SPF or germfree conditions




SPF wild type 23 ,1
SPF IL-10 deficient 25 1,037 6 105*
Germfree heterozygote 10 ,1
Germfree IL-10 deficient 21 ,1
a *, significantly different from all other groups (P , 0.05); for statistical
comparison, all other groups were assigned a mean value of 1.
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The combination of the six colitis-related bacteria used in
the present study readily provoked colitis in HLA-B27 trans-
genic rats which approximated that seen with SPF bacteria
(39). The observation that adult germfree IL-10-deficient mice
colonized with these same colitis-related flora had delayed
onset of very mild colitis compared to that of the germfree
mice moved to SPF conditions suggests that all bacterial strains
do not have equal capacity to induce intestinal inflammation.
Importantly, the mild nature of colitis induced in these mice
colonized with the six identical organisms which induce aggres-
sive colitis in the HLA-B27 transgenic rat further supports the
notion that other factors, in particular the host genetic back-
ground, play a critical role in the development of experimental
colitis in response to any given bacterial stimulus. Indeed,
inbred C57BL/6 mice with the IL-10 deletion develop mild,
delayed-onset colitis in striking contrast to the early and ag-
gressive colitis of IL-10-deficient mice of the 129 Sv back-
ground (3). Similarly, we did not observe colonic adenocarci-
nomas in either the SPF or germfree IL-10-deficient outbred
(C57BL/6 3 129) mice followed for up to 38 weeks of age, as
were observed in 6-month-old 129 Sv mice (3). Alternatively to
differences in genetic background, quantitative differences in
the numbers of each bacterium (not measured in this study)
may have influenced the development of inflammation, partic-
ularly if pro-inflammatory bacteria were limited in their pro-
liferation by noninflammatory bacteria. Further studies will be
necessary to determine the dominant enteric bacterial strains
that induce or perpetuate colitis in IL-10-deficient mice.
These results point out the inflammatory consequences of
unbalanced immune responses to resident nonpathogenic bac-
teria but do not completely explain the mechanisms by which
inflammation is mediated. Possible unregulated mucosal pro-
duction of IL-12 as suggested by our results could result in
excess production of IFN-g, a proinflammatory Th1 cytokine
known to alter epithelial barrier integrity in vitro. Preliminary
observations with IL-10-deficient mice suggest that even in the
germfree state these mice have lower colonic mucosal electri-
cal resistance than do wild-type mice (46a). Recombinant
IL-10 has been shown to prevent IFN-g-mediated damage to
epithelial barrier integrity in cultured T84 cells (31). It thus is
possible that IL-10-deficient mice have inherent defects in mu-
cosal barrier function that allow endogenous luminal bacteria
and/or bacterial products to induce colonic inflammation. Al-
ternatively, IL-10-deficient mucosal macrophages exposed to
bacterial antigens could have overly aggressive cytokine pro-
duction and antigen-presenting activities in the absence of
immunosuppressive IL-10, perhaps resulting in activation of T
lymphocytes to endogenous bacterial antigens. Exacerbations
of pathologic immune responses have been described in IL-
10-deficient mice infected with Trypanosoma cruzi (23) or Tox-
oplasma gondii (21). These results have been attributed to an
intrinsic lack of down regulation of Th1 immune responses,
since administration of exogenous recombinant IL-10 or neu-
tralizing anti-IL-12 antibodies abrogates pathologic responses
in these models and disease in the infected mice is not attrib-
utable to uncontrolled proliferation of the infecting organism.
Lastly, an unbalanced cytokine environment could alter anti-
gen-presenting cell function (13) to lead to immune responses
to normally nonimmunogenic antigens. Applying these obser-
vations to resident luminal bacteria, we speculate that in the
genetically susceptible host, a dysregulated immune response
could establish the cytokine milieu which promotes pathologic
responses to normally nonpathogenic luminal bacterial anti-
gens.
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M. Neurath. 1996. Tolerance towards resident intestinal flora in mice is
abrogated in experimental colitis and restored by treatment with interleu-
kin-10 or antibodies to interleukin-12. Eur. J. Immunol. 26:934–938.
18. Ehrhardt, R. O., B. R. Ludviksson, B. Gray, M. Neurath, and W. Strober.
1997. Induction and prevention of colonic inflammation in IL-2 deficient
mice. J. Immunol. 158:566–573.
19. Fiorentino, D. F., A. Zlotnik, T. R. Mossman, M. H. Howard, and A.
O’Garra. 1991. IL-10 inhibits cytokine production by activated macrophages.
J. Immunol. 147:3815–3822.
20. Fiorentino, D. F., A. Zlotnik, P. Vieira, T. R. Mossman, M. Howard, K. W.
Moore, and A. O’Garra. 1991. IL-10 acts on the antigen presenting cell to
inhibit cytokine production by Th1 cells. J. Immunol. 146:3444–3451.
21. Gazzinelli, R. T., M. Wysocka, S. Hieny, T. Scharton-Kersten, A. Cheever, R.
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